What Is a Term Sheet: Clauses, Terms, and 2026 Benchmarks

Knowing what is a term sheet is the operational starting point for any institutional fundraise. It is a non-binding document that defines the structural terms of a VC investment before the definitive legal agreements are drafted. Not a contract: the architecture of one. What gets agreed at this stage shapes who captures value at exit, who controls the board in operational decisions, and how dilution compounds across future financing rounds.

According to a 2026 analysis of 711 UK term sheets by HSBC Innovation Banking, covering 29 law firms and £11.2 billion in aggregate investment value, Series B and C+ rounds now represent 31% of all term sheets, up from 26% in 2024. That five-point shift reflects a concentration of capital toward scaled companies. For operators, it means the deal pool is less evenly distributed across stages than it was two years ago.

What a term sheet covers: two sections, most of the leverage

Every term sheet divides into two functional blocks. The first is economic terms: investment amount, pre-money valuation, option pool, liquidation preference, and anti-dilution structure. The second is governance terms: board composition, protective provisions, information rights, and co-sale or drag-along mechanics.

The economic block determines who captures value in a liquidity event. The governance block determines who can block or approve the decisions that create one.

Founders negotiating a term sheet for the first time typically over-index on valuation. Operators who have completed multiple rounds know that a 1x participating liquidation preference on a $10M round can eliminate founder returns at a $40M exit more efficiently than a 10-point valuation miss. The headline number is the least reliable indicator of deal quality.

The two blocks are not independent. A high pre-money valuation combined with aggressive protective provisions and a participating liquidation preference is a structurally worse deal than a lower valuation with clean governance. Analyzing a term sheet means reading the full document, not anchoring on the headline.

Pre-money valuation and the option pool effect

Pre-money valuation is the most visible number on a term sheet. It is not the most consequential one in practical outcomes.

The option pool matters more in many scenarios. When an investor proposes a $20M pre-money valuation with a 20% option pool increase funded from the pre-money, the effective pre-money founders are selling against is $16M. This practice is standard. Founders who model dilution on both the stated pre-money and the post-option-pool number before signing have a more accurate picture of what the deal actually means for their ownership percentage at close.

In 2026, median Series A pre-money valuations for US startups are in the $35-45M range, down from the $55-65M peaks of 2021 but recovering from the $25-30M troughs of 2023. The option pool as a percentage of post-money is trending toward 10-15% at Series A, down from the 15-20% common in 2021-2022 rounds. These benchmarks are useful calibration points, but the relevant comparison is always the specific vertical, stage, and revenue base, not the macro average.

The pre-money valuation also establishes the baseline for anti-dilution calculations in any subsequent down round. A valuation set significantly above revenue multiples at the time of closing is not a neutral choice: it creates a higher bar for the next round to clear and increases the probability that anti-dilution provisions will be triggered.

Liquidation preference: the clause that controls exit economics

Liquidation preference defines what investors receive before common shareholders, including founders, employees, and advisors, see any proceeds in a liquidity event.

The 2026 market standard at Series A is 1x non-participating preferred. This means investors receive 1x their invested capital OR convert to common stock and share pro-rata in the proceeds, whichever produces a higher return. At a strong exit multiple, investors convert to common. At a moderate exit, they take the preference.

Participating preferred works differently and is more investor-favorable: investors receive 1x their invested capital AND then share pro-rata in the remaining proceeds alongside common shareholders. This structure can eliminate founder and employee returns at low-to-mid exit multiples.

The practical model to run: on a $5M Series A at 1x participating preferred on a $20M exit, investors take the $5M preference plus a proportional share of the remaining $15M. On the same exit with 1x non-participating preferred, investors choose between taking the $5M or converting to common and sharing pro-rata. The delta in founder proceeds at a $20M exit is not marginal.

A term sheet can also specify a 2x or 3x liquidation preference, where investors receive 2x or 3x their invested capital before common shareholders see proceeds. These multiples were more common in down-market deal environments and are now rare at Series A. Their presence in a current-market term sheet is a signal worth interrogating.

According to the 2026 HSBC term sheet dataset, participating preferences declined in frequency as investor competition at Series A and B increased. The shift toward non-participating structures at scale reflects a more competitive deal environment, not a concession by investors.

Anti-dilution: three structures, one that is market standard

Anti-dilution provisions protect investors from dilution in a down round by adjusting the price at which their preferred shares convert to common. Three structures exist, and their outcomes are not equivalent.

Full ratchet adjusts the investor's conversion price to exactly match the lower price in the down round, regardless of how many shares are issued at the lower price. It is the most investor-favorable structure and is rarely seen at Series A or B in a competitive market environment.

Broad-based weighted average adjusts the conversion price proportionally, accounting for all shares outstanding before and after the new financing. This is the market standard for Series A and B. It produces a more balanced adjustment that reflects the actual dilutive impact of the down round.

Narrow-based weighted average uses a smaller share count denominator, producing a more investor-favorable adjustment than broad-based. It appears in term sheets from funds operating with stronger negotiating position at a specific round.

For founders at Series A in 2026, broad-based weighted average anti-dilution is the baseline expectation. A term sheet proposing narrow-based or full ratchet should be benchmarked against comparable deals in the same vertical. The deviation is material and its effects compound in any subsequent down round.

Protective provisions: the operational veto map

Protective provisions are consent rights: a list of decisions the company cannot make without investor approval. They are not uniformly material. The section needs to be read clause by clause, not accepted as a block.

Standard provisions include: issuing new equity, amending the certificate of incorporation, taking on debt above a defined threshold, entering change-of-control transactions, and authorizing liquidation or dissolution. These represent defensible investor protections with limited operational friction under normal conditions.

Non-standard provisions expand this list to include: hiring or firing the CEO, setting executive compensation above a threshold, entering contracts above a defined size, or changing the primary business. These clauses transfer operational control in ways that are not always visible in headline term negotiations and are not always flagged by advisors focused on the economic terms.

The operational test for any protective provision: what happens if this right is exercised at an inconvenient moment? A provision that allows an investor to block a strategic partnership during a fundraise has a measurable cost. A provision that requires investor approval for executive compensation creates friction in competitive hiring situations. Model the cost per clause for the specific stage and business model. Treat the section as a legal document, not boilerplate.

The 2026 HSBC dataset does not publish a clause-level breakdown of protective provisions, but legal counsel active in the UK and US VC markets consistently note that the governance section of term sheets has expanded in complexity at Series B and C+ as lead investors seek more structured control mechanisms in a higher-stakes deal environment.

Board composition: the governance delta founders overlook

The board section determines who controls the company's strategic decisions after the investment closes. At seed or Series A, a common structure is three seats: two founders, one investor. This preserves founder majority on the board.

As rounds accumulate, board composition shifts. A Series B term sheet might propose five seats: two founders, two investors, one independent director. The independent director selection process matters as much as the seat count. A right for the investor to approve the independent director is a structurally different governance outcome than a jointly-agreed selection process or a neutral third-party nominee.

What operators track in the board section: not just seat count, but the consent mechanics for major decisions, the threshold for what constitutes a board quorum, whether protective provisions can be exercised unilaterally by the investor director without a full board vote, and the conditions under which board composition can be changed.

The 2026 HSBC data identifies board composition as one of the most actively negotiated sections in later-stage deals, as the concentration of capital among fewer lead investors at Series B and C+ increases the negotiating asymmetry.

2026 term sheet benchmarks: what 711 analyzed deals show

The HSBC Innovation Banking 2026 VC Term Sheet Guide analyzed 711 term sheets across 29 law firms, covering £11.2 billion in aggregate investment value. The dataset is UK-focused but reflects patterns consistent with comparable US market data.

Key signals from the 2026 dataset:

• Series B and C+ deals: 31% of all term sheets, up from 26% in 2024, the largest single-year stage shift in three years.

• AI and generative AI deals: 35% of term sheets, up from 15% in 2021.

• Participating preferences: declining frequency as deal competition at Series A and B increased.

• Seed stage: identified as the structurally optimal stage to negotiate favorable long-term terms, as provisions set at seed propagate into subsequent rounds without automatic reset.

The shift toward later-stage concentration is a structural signal for operators approaching a Series B or C in 2026. Investors running those transactions week-over-week have more comparable transaction data than founders who close one or two institutional rounds in a four-year window. This information asymmetry is a factor in term sheet negotiations that does not appear in the term sheet itself.

From term sheet to definitive docs: where terms shift

A term sheet is non-binding except for two provisions: exclusivity (the no-shop clause, typically 30-60 days) and confidentiality. Every other provision is subject to revision in the definitive agreements: the Stock Purchase Agreement, Investor Rights Agreement, Voting Agreement, and Right of First Refusal and Co-Sale Agreement.

Three areas where terms commonly move between term sheet and definitive docs:

Representations and warranties: The SPA includes company representations about its current legal and financial state. Material Adverse Change carve-outs, indemnification caps, and survival periods are negotiated here and rarely appear in the term sheet. These provisions can have significant post-close implications in a transaction where the company's state at closing differs from representations made during due diligence.

Information rights: A term sheet might specify "standard information rights." The Investor Rights Agreement defines what standard means operationally: quarterly financials only, or monthly management accounts, or access to the cap table and board minutes. The distinction affects ongoing administrative overhead and the level of operational visibility investors have between board meetings.

Registration rights and co-sale: Not visible in a standard term sheet summary. The IRA includes drag-along provisions, piggyback registration rights, and co-sale mechanics that affect how exits are structured and who has the ability to participate in or block a secondary transaction.

Founders who treat the term sheet as the finish line of negotiation regularly discover that the definitive docs contain provisions not surfaced in the term sheet stage. Specialized VC legal counsel, not general commercial counsel, is the single highest-return cost allocation in the term sheet negotiation budget. The cost differential between the two is not material relative to the value of a well-negotiated governance document.

Key parameters to benchmark across term sheets

Primary measurable parameters and 2026 benchmarks:

• Pre-money valuation: measure against revenue multiple peers. Series A: $35-45M median (US) in 2026.

• Option pool: measure as percentage of post-money. 10-15% at Series A is current market range.

• Liquidation preference: 1x non-participating preferred is the 2026 Series A standard. Participating preferred is the exception to flag.

• Anti-dilution: broad-based weighted average is the standard. Full ratchet and narrow-based WA are investor-favorable deviations.

• Board seats: 2 founders, 1 investor is the Series A norm. Founder majority shifts at Series B.

• No-shop period: 30-60 days standard. Shorter windows are founder-favorable; longer windows increase exposure if terms are revised during due diligence.

The delta between market standard and a specific term sheet's provisions is the negotiation surface. Operators who benchmark their term sheets against comparable deals in the same vertical, stage, and geography have a more accurate picture of what they are signing than operators working from a single reference point.

Signals from the 2026 HSBC dataset confirm that the current deal environment at Series A is structurally more founder-favorable on economics than the 2021-2022 peak, and that provisions set at seed continue to have compounding effects on governance and economics in subsequent rounds. The term sheet is not a standalone document: it is the first version of a governance structure that will operate for the duration of the company.